Insider Buying and Selling - GNLX

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
05/12/2025	05/13/2025	Cappello Joseph VP, Pharmaceutical Development Officer	Sell	-4,737 @ $2.92	($13,832.04)	52,266	(-8.31%)	Direct
05/12/2025	05/13/2025	Ryder Sean General Counsel Officer	Sell	-4,475 @ $2.92	($13,067.00)	47,621	(-8.59%)	Direct
05/12/2025	05/13/2025	Smalling Ralph Head of Regulatory Officer	Sell	-1,259 @ $2.92	($3,676.28)	34,760	(-3.50%)	Direct
05/12/2025	05/13/2025	Yu Yong VP, Clinical Trial Operations Officer	Sell	-5,579 @ $2.92	($16,290.68)	47,640	(-10.48%)	Direct
05/12/2025	05/13/2025	Zindrick Thomas President and CEO CEO Director	Sell	-10,764 @ $2.92	($31,430.88)	191,447	(-5.32%)	Direct
12/30/2024	12/30/2024	Tyree James L Director	Sell	-3,460 @ $2.46	($8,511.60)	45,791	(-7.03%)	Direct
12/16/2024	12/18/2024	Cappello Joseph VP, Pharmaceutical Development Officer	Sell	-6,300 @ $2.34	($14,742.00)	14,653	(-30.07%)	Direct
12/16/2024	12/18/2024	Smalling Ralph Head of Regulatory Officer	Sell	-2,510 @ $2.34	($5,873.40)	16,322	(-13.33%)	Direct
12/16/2024	12/18/2024	Zak Lourie S. Chief Financial Officer CFO	Sell	-2,103 @ $2.34	($4,921.02)	40,802	(-4.90%)	Direct
12/16/2024	12/18/2024	Zindrick Thomas President and CEO CEO Director	Sell	-14,315 @ $2.34	($33,497.10)	37,372	(-27.70%)	Direct

GENELUX CORP - GNLX